Delivery Order SPE2DX22D0010-SPE2D826FCH47
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,666.14 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,576.80 by the Defense Logistics Agency's Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award valued at $2,072.88 from the Defense Logistics Agency's Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The order will be fulfilled at...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $263,380.55 by the Defense Logistics Agency's Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026). The awardee, headquartered in...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $35,639.49 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. This Firm Fixed Price contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a competitive award with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,200.68 on January 8, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order will be completed by January 9, 2026, and will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,593.82 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,171.60 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price, non-set-aside contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026. The contract represents a single...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCH47Delivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $25,429.74 by the Defense Logistics Agency's Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside delivery order represents a task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's extensive IDC portfolio and consistent record of competitive awards demonstrate its capability to efficiently fulfill government contracts for essential pharmaceutical and medical commodities required by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.4k | 1/8/26 |